These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 16407653)

  • 1. Functional Vitamin E deficiency in ApoE4 patients with Alzheimer's disease.
    Mas E; Dupuy AM; Artero S; Portet F; Cristol JP; Ritchie K; Touchon J
    Dement Geriatr Cogn Disord; 2006; 21(3):198-204. PubMed ID: 16407653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of apolipoprotein E polymorphism with age-related macular degeneration and Alzheimer's disease in south-western Hungary.
    Kovács KA; Pámer Z; Kovács A; Fekete S; Miseta A; Kovács B; Kovács GL
    Ideggyogy Sz; 2007 Mar; 60(3-4):169-72. PubMed ID: 17451062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of apoE genotype and vitamin E on biomarkers of oxidative stress in cultured neuronal cells and the brain of targeted replacement mice.
    Huebbe P; Jofre-Monseny L; Boesch-Saadatmandi Ch; Minihane AM; Rimbach G
    J Physiol Pharmacol; 2007 Dec; 58(4):683-98. PubMed ID: 18195481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of antioxidants are not associated with Alzheimer's disease or cognitive decline.
    Engelhart MJ; Ruitenberg A; Meijer J; Kiliaan A; van Swieten JC; Hofman A; Witteman JC; Breteler MM
    Dement Geriatr Cogn Disord; 2005; 19(2-3):134-9. PubMed ID: 15627760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brain.
    Ramassamy C; Averill D; Beffert U; Theroux L; Lussier-Cacan S; Cohn JS; Christen Y; Schoofs A; Davignon J; Poirier J
    Neurobiol Dis; 2000 Feb; 7(1):23-37. PubMed ID: 10671320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.
    Tayler H; Fraser T; Miners JS; Kehoe PG; Love S
    J Alzheimers Dis; 2010; 22(4):1363-73. PubMed ID: 20930272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medial temporal lobe atrophy, apolipoprotein genotype, and plasma homocysteine in Sri Lankan patients with Alzheimer's disease.
    de Silva HA; Gunatilake SB; Johnston C; Warden D; Smith AD
    Exp Aging Res; 2005; 31(3):345-54. PubMed ID: 16036726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E phenotypes in healthy normal controls and demented subjects with Alzheimer's disease and vascular dementia in Mie Prefecture of Japan.
    Nakayama S; Kuzuhara S
    Psychiatry Clin Neurosci; 1999 Dec; 53(6):643-8. PubMed ID: 10687744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians.
    Osuntokun BO; Sahota A; Ogunniyi AO; Gureje O; Baiyewu O; Adeyinka A; Oluwole SO; Komolafe O; Hall KS; Unverzagt FW
    Ann Neurol; 1995 Sep; 38(3):463-5. PubMed ID: 7668835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of vascular comorbidities on the antioxidant defense system in Alzheimer's disease].
    Polidori MC; Stahl W; De Spirt S; Pientka L
    Dtsch Med Wochenschr; 2012 Feb; 137(7):305-8. PubMed ID: 22318842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease.
    Guidi I; Galimberti D; Lonati S; Novembrino C; Bamonti F; Tiriticco M; Fenoglio C; Venturelli E; Baron P; Bresolin N; Scarpini E
    Neurobiol Aging; 2006 Feb; 27(2):262-9. PubMed ID: 16399211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia.
    Paragh G; Balla P; Katona E; Seres I; Egerházi A; Degrell I
    Eur Arch Psychiatry Clin Neurosci; 2002 Apr; 252(2):63-7. PubMed ID: 12111338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SREBP-1a polymorphism influences the risk of Alzheimer's disease in carriers of the ApoE4 allele.
    Spell C; Kölsch H; Lütjohann D; Kerksiek A; Hentschel F; Damian M; von Bergmann K; Rao ML; Maier W; Heun R
    Dement Geriatr Cogn Disord; 2004; 18(3-4):245-9. PubMed ID: 15286454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of beta-amyloid (1-42) in Alzheimer's disease and mild cognitive impairment.
    Pesaresi M; Lovati C; Bertora P; Mailland E; Galimberti D; Scarpini E; Quadri P; Forloni G; Mariani C
    Neurobiol Aging; 2006 Jun; 27(6):904-5. PubMed ID: 16638622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.
    Marra C; Bizzarro A; Daniele A; De Luca L; Ferraccioli M; Valenza A; Brahe C; Tiziano FD; Gainotti G; Masullo C
    Dement Geriatr Cogn Disord; 2004; 18(2):125-31. PubMed ID: 15211066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
    Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
    Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genotype and phenotype of apolipoprotein E in patients with Alzheimer's disease in Castille and Leon].
    Cacho J; Breñas T; González C; Arroyo T; Arcaya J; García R; Guerrero AL; Navajo JA; García C; González Buitrago JM
    Neurologia; 1997 Nov; 12(9):384-8. PubMed ID: 9471175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin E in neurodegenerative disorders: Alzheimer's disease.
    Kontush K; Schekatolina S
    Ann N Y Acad Sci; 2004 Dec; 1031():249-62. PubMed ID: 15753151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of apolipoprotein E (apoE) phenotype on the apoE content of CSF-HDL in children.
    Hirayama S; Miida T; Obayashi K; Yamazaki F; Yamazaki-Sakurai M; Ito M; Saito Y; Hanyu O; Suzuki K; Aizawa Y
    Clin Chim Acta; 2005 Jun; 356(1-2):110-6. PubMed ID: 15936307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between apolipoprotein E4 and lipid metabolism is impaired in Alzheimer's disease.
    Dupuy AM; Mas E; Ritchie K; Descomps B; Badiou S; Cristol JP; Touchon J
    Gerontology; 2001; 47(4):213-8. PubMed ID: 11408727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.